Literature DB >> 9802316

Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system.

G Haskó1, C Szabó.   

Abstract

The sympathetic nervous system innervates immune organs and, when activated, releases its signaling molecules in the vicinity of immune cells. The released molecules include the "classical" transmitters norepinephrine and epinephrine and the co-transmitters ATP and adenosine. Immune cells express various adrenergic and purinergic receptors that are sensitive to these molecules, and the production of immune/inflammatory mediators (cytokines, chemokines, and free radicals) is modulated by activation of these receptors. Notably, the production of tumor necrosis factor-alpha, interleukin-6, -10, and -12, and the chemokine macrophage inflammatory protein 1alpha and the production of the free radical nitric oxide, produced by the inducible nitric oxide synthase, have been shown to be altered by activation of these receptors. Alterations in the production of the immune mediators may contribute to the development of various diseases. On the other hand, novel experimental therapies based on the modulation of adrenergic or purinergic receptors on immune cells are emerging. Such approaches may have beneficial effects in limiting tissue injury and suppressing symptoms in certain pathophysiological states.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802316     DOI: 10.1016/s0006-2952(98)00153-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  44 in total

1.  Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase C.

Authors:  M K Ho; L Y Yung; J S Chan; J H Chan; C S Wong; Y H Wong
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 2.  IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses.

Authors:  G Haskó; C Szabó
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 3.  Receptor-mediated interaction between the sympathetic nervous system and immune system in inflammation.

Authors:  G Haskó
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 4.  The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation.

Authors:  Valentin A Pavlov; Hong Wang; Christopher J Czura; Steven G Friedman; Kevin J Tracey
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

5.  Norepinephrine and adenosine-5'-triphosphate synergize in inducing IL-6 production by human dermal microvascular endothelial cells.

Authors:  Lori L Stohl; Julie B Zang; Wanhong Ding; Michela Manni; Xi K Zhou; Richard D Granstein
Journal:  Cytokine       Date:  2013-09-08       Impact factor: 3.861

6.  New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC.

Authors:  Leszek Rybaczyk; Andrew Rozmiarek; Kristin Circle; Iveta Grants; Bradley Needleman; Jacqueline E Wunderlich; Kun Huang; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

Review 7.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

8.  Gender differences in stimulated cytokine production following acute psychological stress.

Authors:  Aric A Prather; Judith E Carroll; Jacqueline M Fury; Kevin K McDade; Diana Ross; Anna L Marsland
Journal:  Brain Behav Immun       Date:  2008-12-06       Impact factor: 7.217

9.  Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins.

Authors:  Ranit Naor; Vered Domankevich; Shaily Shemer; Luba Sominsky; Ella Rosenne; Ben Levi; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2008-10-08       Impact factor: 7.217

Review 10.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.